Literature DB >> 9068917

A practical approach to torsade de pointes.

D M Roden1.   

Abstract

The term torsade de pointes refers to polymorphic ventricular tachycardia that occurs in the setting of an abnormally long QT interval. While the most common cause is treatment with QT prolonging drugs, torsade de pointes also occurs in the congenital long QT syndromes and in the setting of acquired heart block or severe electrolyte disturbance, notably hypokalemia. Among QT prolonging drugs that cause torsade de pointes, both antiarrhythmics and "noncardioactive" drugs have been recognized. The electrocardiographic features of torsade de pointes include labile QT intervals, prominent U waves, and a "pause-dependent" onset of the arrhythmia. Treatment consists of recognition of the syndrome, correction of underlying electrolyte abnormalities, and withdrawal of any offending drugs. Magnesium, isoproterenol, or cardiac pacing provides specific antiarrhythmic therapy in torsade de pointes.

Entities:  

Mesh:

Year:  1997        PMID: 9068917      PMCID: PMC6656095          DOI: 10.1002/clc.4960200318

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  15 in total

1.  Preventing deaths from long QT syndrome.

Authors:  S F Pilley
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

2.  Static and Dynamic Electrocardiographic Patterns Preceding Torsades de Pointes in the Acquired and Congenital Long QT Syndrome.

Authors:  Jp Couderc; J Xia; X Xu; S Kaab; M Hinteeser; W Zareba
Journal:  Comput Cardiol (2010)       Date:  2010-09-26

3.  Ziprasidone and hypokalemia: a case of 2 predisposing factors for QTc prolongation without development of torsades de pointes.

Authors:  B Rush Simpson; Robert P Albanese
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

4.  Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1.

Authors:  U C Hoppe; E Marbán; D C Johns
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

5.  Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome.

Authors:  I Arrighi; M Bloch-Faure; F Grahammer; M Bleich; R Warth; R Mengual; M D Drici; J Barhanin; P Meneton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

6.  Hypocalcemia Presenting as Life Threatening Torsades de Pointes with Prolongation of QTc Interval.

Authors:  Shibba Takkar Chhabra; Shivani Mehta; Sandeep Chhabra; Manikant Singla; Naved Aslam; Bishav Mohan; Gurpreet Singh Wander
Journal:  Indian J Clin Biochem       Date:  2017-08-01

Review 7.  The role of magnesium in the emergency department.

Authors:  P Kaye; I O'Sullivan
Journal:  Emerg Med J       Date:  2002-07       Impact factor: 2.740

8.  Evaluation of Ondansetron-induced QT interval prolongation in the prophylaxis of postoperative emesis.

Authors:  Sampa Dutta Gupta; Ranabir Pal; Aniruddha Sarkar; Sudakshina Mukherjee; Koel Mitra; Suddhadeb Roy; Debabrata Sarbapalli; Kanak Kanti Kundu; Forhad Akhtar Zaman; Sumit Kar
Journal:  J Nat Sci Biol Med       Date:  2011-01

9.  The fallacies of QT correction.

Authors:  Yash Lokhandwala; S C Toal
Journal:  Indian Pacing Electrophysiol J       Date:  2003-10-01

10.  Acquired Long QT Syndrome Manifesting with Torsades de Pointes in a Patient with Panhypopituitarism due to Radiotherapy.

Authors:  Dae Gil Kang; Sung Eun Kim; Myoung Soo Park; Eun Jung Kim; Jun Hee Lee; Dae Gyun Park; Kyoo Rok Han; Dong Jin Oh
Journal:  Korean Circ J       Date:  2013-05-31       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.